This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
SIU 2017
SIU 2017
Prostate Cancer
Kidney Cancer
Bladder Cancer
SIU 2017 Bladder Cancer
Viewing 1-20 of 53 articles
SIU 2017: Predicting Tumour Recurrence in Patients Treated with Bacillus Calmette-Guérin
SIU 2017: Red Patches Seen during Endoscopic Surveillance of Bladder Cancer – When Should we Biopsy?
SIU 2017: Factors Predicting Concomitant Carcinoma in Situ in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer
SIU 2017: Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) by Institution Performing the Initial TURBT: Comparative Analyses between Referred and Non-Referred Group
SIU 2017: Dynamic Real-Time Microscopy of Bladder Neoplasms Using Confocal Laser Endomicroscopy
SIU 2017: Relation of ALDH1a and CD44 with Clinicopathological Factors in Transitional and Squamous Cell Carcinomas of Urinary Bladder
SIU 2017: Overexpression of Epidermal Growth Factor Receptor Predicts Bladder Cancer Local Aggressiveness
SIU 2017: Second Look Transurethral Resection of Bladder Tumor: Is It Necessary in All T1 and/or High Grade Tumors?
SIU 2017: Lateral Bladder Neck Dissection Technique and Triple-Layer Posterior Bladder Wall Reconstruction Lead to Early Removal of Foley Catheter and Improved Urinary Continence after Robotic-Assisted Radical Prostatectomy
SIU 2017: Discerning Predictors for Gender Differences in Survival Outcomes for Patients Treated for Bladder Cancer
SIU 2017: Use of Concurrent Chemotherapy with Radiation Therapy for Bladder Cancer in the United States: A Quality of Care Comparative Effectiveness Study
SIU 2017: Identification of Factors Associated with Delayed Haematuria Assessment
SIU 2017: Predictors of Bladder Cancer Following Hematuria
SIU 2017: En-Bloc Transurethral Resection of Non muscle invasive Bladder Cancer: Pathological Effectiveness
SIU 2017: Upper Tract Urothelial Carcinoma
SIU 2017: New Diagnostic Techniques in Cystoscopy
SIU 2017: Is It Always Necessary to Perform Restaging TUR for cT1 Urothelial Carcinoma of the Bladder?
SIU 2017: The Role of Lymphadenectomy in the Oligometastatic and Salvage Prostate Cancer Setting
The Optimal Treatment of Muscle Invasive Urothelial Bladder Cancer with Neoadjuvant Chemotherapy with Cystectomy
SIU 2017: Controversies in Urology--Bladder Cancer: Old is Gold!
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free